Imricor Medical Systems Inc
ASX:IMR

Watchlist Manager
Imricor Medical Systems Inc Logo
Imricor Medical Systems Inc
ASX:IMR
Watchlist
Price: 0.93 AUD 0.54% Market Closed
Market Cap: 188.7m AUD
Have any thoughts about
Imricor Medical Systems Inc?
Write Note

Intrinsic Value

IMR's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one IMR stock under the Base Case scenario is 0.46 AUD. Compared to the current market price of 0.93 AUD, Imricor Medical Systems Inc is Overvalued by 51%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IMR Intrinsic Value
0.46 AUD
Overvaluation 51%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Imricor Medical Systems Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for IMR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about IMR?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Imricor Medical Systems Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Imricor Medical Systems Inc

Provide an overview of the primary business activities
of Imricor Medical Systems Inc.

What unique competitive advantages
does Imricor Medical Systems Inc hold over its rivals?

What risks and challenges
does Imricor Medical Systems Inc face in the near future?

Has there been any significant insider trading activity
in Imricor Medical Systems Inc recently?

Summarize the latest earnings call
of Imricor Medical Systems Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Imricor Medical Systems Inc.

Provide P/S
for Imricor Medical Systems Inc.

Provide P/E
for Imricor Medical Systems Inc.

Provide P/OCF
for Imricor Medical Systems Inc.

Provide P/FCFE
for Imricor Medical Systems Inc.

Provide P/B
for Imricor Medical Systems Inc.

Provide EV/S
for Imricor Medical Systems Inc.

Provide EV/GP
for Imricor Medical Systems Inc.

Provide EV/EBITDA
for Imricor Medical Systems Inc.

Provide EV/EBIT
for Imricor Medical Systems Inc.

Provide EV/OCF
for Imricor Medical Systems Inc.

Provide EV/FCFF
for Imricor Medical Systems Inc.

Provide EV/IC
for Imricor Medical Systems Inc.

Show me price targets
for Imricor Medical Systems Inc made by professional analysts.

What are the Revenue projections
for Imricor Medical Systems Inc?

How accurate were the past Revenue estimates
for Imricor Medical Systems Inc?

What are the Net Income projections
for Imricor Medical Systems Inc?

How accurate were the past Net Income estimates
for Imricor Medical Systems Inc?

What are the EPS projections
for Imricor Medical Systems Inc?

How accurate were the past EPS estimates
for Imricor Medical Systems Inc?

What are the EBIT projections
for Imricor Medical Systems Inc?

How accurate were the past EBIT estimates
for Imricor Medical Systems Inc?

Compare the revenue forecasts
for Imricor Medical Systems Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Imricor Medical Systems Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Imricor Medical Systems Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Imricor Medical Systems Inc compared to its peers.

Compare the P/E ratios
of Imricor Medical Systems Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Imricor Medical Systems Inc with its peers.

Analyze the financial leverage
of Imricor Medical Systems Inc compared to its main competitors.

Show all profitability ratios
for Imricor Medical Systems Inc.

Provide ROE
for Imricor Medical Systems Inc.

Provide ROA
for Imricor Medical Systems Inc.

Provide ROIC
for Imricor Medical Systems Inc.

Provide ROCE
for Imricor Medical Systems Inc.

Provide Gross Margin
for Imricor Medical Systems Inc.

Provide Operating Margin
for Imricor Medical Systems Inc.

Provide Net Margin
for Imricor Medical Systems Inc.

Provide FCF Margin
for Imricor Medical Systems Inc.

Show all solvency ratios
for Imricor Medical Systems Inc.

Provide D/E Ratio
for Imricor Medical Systems Inc.

Provide D/A Ratio
for Imricor Medical Systems Inc.

Provide Interest Coverage Ratio
for Imricor Medical Systems Inc.

Provide Altman Z-Score Ratio
for Imricor Medical Systems Inc.

Provide Quick Ratio
for Imricor Medical Systems Inc.

Provide Current Ratio
for Imricor Medical Systems Inc.

Provide Cash Ratio
for Imricor Medical Systems Inc.

What is the historical Revenue growth
over the last 5 years for Imricor Medical Systems Inc?

What is the historical Net Income growth
over the last 5 years for Imricor Medical Systems Inc?

What is the current Free Cash Flow
of Imricor Medical Systems Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Imricor Medical Systems Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Imricor Medical Systems Inc

Current Assets 4.1m
Cash & Short-Term Investments 1.5m
Receivables 312.1k
Other Current Assets 2.3m
Non-Current Assets 3.6m
PP&E 2.9m
Other Non-Current Assets 727.5k
Current Liabilities 2.8m
Accounts Payable 757k
Accrued Liabilities 1.4m
Other Current Liabilities 714.1k
Non-Current Liabilities 11.3m
Long-Term Debt 7.8m
Other Non-Current Liabilities 3.5m
Efficiency

Earnings Waterfall
Imricor Medical Systems Inc

Revenue
824.3k USD
Cost of Revenue
-1.7m USD
Gross Profit
-913.4k USD
Operating Expenses
-14.9m USD
Operating Income
-15.8m USD
Other Expenses
-4.5m USD
Net Income
-20.3m USD

Free Cash Flow Analysis
Imricor Medical Systems Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Imricor announced significant developments in Q1 of 2024, including the launch of new commercial sites and regulatory advancements in the Middle East and Europe. The company reported operating cash outflows of $4.7 million and secured $5.1 million from financing activities. With Saudi FDA approval and pending TGA clearance in Australia, Imricor aims to expand globally. A pivotal U.S. FDA trial for atrial flutter is underway, and the first ventricular tachycardia ablation with MRI guidance is planned. Despite delays, the commercialization effort is progressing with increased procedural volumes and new site activations scheduled throughout the year.

What is Earnings Call?
Fundamental Scores

IMR Profitability Score
Profitability Due Diligence

Imricor Medical Systems Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional Revenue Growth Forecast
Exceptional ROE
Exceptional 1-Year Revenue Growth
42/100
Profitability
Score

Imricor Medical Systems Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

IMR Solvency Score
Solvency Due Diligence

Imricor Medical Systems Inc's solvency score is 29/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
29/100
Solvency
Score

Imricor Medical Systems Inc's solvency score is 29/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IMR Price Targets Summary
Imricor Medical Systems Inc

Wall Street analysts forecast IMR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMR is 1.1 AUD with a low forecast of 1.09 AUD and a high forecast of 1.13 AUD.

Lowest
Price Target
1.09 AUD
17% Upside
Average
Price Target
1.1 AUD
18% Upside
Highest
Price Target
1.13 AUD
22% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for IMR?

Click here to dive deeper.

Dividends

Imricor Medical Systems Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for IMR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

IMR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Imricor Medical Systems Inc Logo
Imricor Medical Systems Inc

Country

United States of America

Industry

Health Care

Market Cap

188.7m AUD

Dividend Yield

0%

Description

Imricor Medical Systems, Inc. is a medical device company, which engages in the design, manufacture, and distribution of magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures. The company is headquartered in Burnsville, Minnesota. The company went IPO on 2019-08-30. The firm is engaged in designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. Its products include Vision-mitral regurgitation (MR) Ablation Catheter, Advantage-MR electrophysiology (EP) Recorder/Stimulator and Vision-MR Dispersive Electrode. The Vision-MR Ablation Catheter is designed to work under real-time MRI guidance. Advantage-MR EP Recorder/Stimulator System provides technology that allows physicians to utilize both the EP recording system and a cardiac stimulator while ablating within the iCMR environment. The firm sells its products to hospitals and clinics for use in iCMR labs, in which ablation procedures using the Vision-MR Ablation Catheter can be performed.

Contact

MINNESOTA
Burnsville
400 Gateway Blvd
+19528188402
imricor.com

IPO

2019-08-30

Employees

-

Officers

President, CEO & Executive Chairman
Mr. Steven Wedan
CFO & VP of Finance
Mr. Jonathon Gut
Chief Operating Officer
Mr. Gregg Stenzel
Vice President of Global Sales
Mr. Greg Englehardt
Vice President of Marketing & Business Development
Mr. Nick Twohy
Company Secretary & Local Agent
Mr. Kobe Lizheng

See Also

Discover More
What is the Intrinsic Value of one IMR stock?

The intrinsic value of one IMR stock under the Base Case scenario is 0.46 AUD.

Is IMR stock undervalued or overvalued?

Compared to the current market price of 0.93 AUD, Imricor Medical Systems Inc is Overvalued by 51%.

Back to Top